MARKET

PGEN

PGEN

Precigen Inc
NASDAQ
4.410
+0.270
+6.52%
After Hours: 4.390 -0.02 -0.45% 19:59 01/16 EST
OPEN
4.310
PREV CLOSE
4.140
HIGH
4.445
LOW
4.120
VOLUME
3.64M
TURNOVER
--
52 WEEK HIGH
5.23
52 WEEK LOW
1.050
MARKET CAP
1.56B
P/E (TTM)
-3.1484
1D
5D
1M
3M
1Y
5Y
1D
Assessing Precigen (PGEN) Valuation After PAPZIMEOS Commercial Momentum And EMA Milestone
Simply Wall St · 2d ago
Is PGEN’s PAPZIMEOS Exclusivity Quietly Redefining Its Competitive Moat in Rare Disease Therapy?
Simply Wall St · 4d ago
Precigen Provides Update On Therapy For Recurrent Respiratory Papillomatosis, To Present Data At J.P. Morgan Healthcare Conference
Benzinga · 5d ago
Precigen Highlights PAPZIMEOS Launch Success at J.P. Morgan Healthcare Conference
Reuters · 5d ago
Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference
PR Newswire · 5d ago
Weekly Report: what happened at PGEN last week (0105-0109)?
Weekly Report · 5d ago
Precigen, Inc. (NASDAQ:PGEN): Are Analysts Optimistic?
Simply Wall St · 01/08 12:29
Weekly Report: what happened at PGEN last week (1229-0102)?
Weekly Report · 01/05 10:36
More
About PGEN
Precigen, Inc. is a discovery and clinical-stage biopharmaceutical company developing gene and cell therapies for improving outcomes for patients with unmet medical needs. The Company’s proprietary technology platforms develop product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It has developed a pipeline of therapies across multiple indications. The Company’s segments include Biopharmaceuticals and Exemplar. The Biopharmaceuticals segment is primarily comprised of the Company's legal entities as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. The Exemplar is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar, its wholly owned subsidiary focused on developing research models and services for healthcare research applications.

Webull offers Precigen Inc stock information, including NASDAQ: PGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PGEN stock methods without spending real money on the virtual paper trading platform.